Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained suppression of disease severity and reduced joint damage

We aimed to compare a transient receptor potential vanilloid 2 (TRPV2) agonist with a TNF inhibitor, and to test the potential of their combination in collagen-induced arthritis (CIA) as a potential future strategy for rheumatoid arthritis (RA). Following the onset of CIA DBA1/j mice were started on...

Descripción completa

Detalles Bibliográficos
Autores principales: Laragione, Teresina, Harris, Carolyn, Gulko, Percio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Autoimmunity / Autoimmune Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038320/
https://www.ncbi.nlm.nih.gov/pubmed/36571199
http://dx.doi.org/10.1093/cei/uxac124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038320/
https://www.ncbi.nlm.nih.gov/pubmed/36571199
http://dx.doi.org/10.1093/cei/uxac124

Ejemplares similares